scispace - formally typeset
Open AccessJournal ArticleDOI

Shaping proteostasis at the cellular, tissue, and organismal level.

Ambre Sala, +2 more
- 01 May 2017 - 
- Vol. 216, Iss: 5, pp 1231-1241
TLDR
This review by Morimoto and colleagues examines mechanisms by which protein homeostasis (proteostasis) is achieved in multicellular organisms and discusses the implications for health and disease.
Abstract
The proteostasis network (PN) regulates protein synthesis, folding, transport, and degradation to maintain proteome integrity and limit the accumulation of protein aggregates, a hallmark of aging and degenerative diseases. In multicellular organisms, the PN is regulated at the cellular, tissue, and systemic level to ensure organismal health and longevity. Here we review these three layers of PN regulation and examine how they collectively maintain cellular homeostasis, achieve cell type-specific proteomes, and coordinate proteostasis across tissues. A precise understanding of these layers of control has important implications for organismal health and could offer new therapeutic approaches for neurodegenerative diseases and other chronic disorders related to PN dysfunction.

read more

Content maybe subject to copyright    Report

Citations
More filters

HSF1 Drives a Transcriptional Program Distinct from Heat Shock to Support Highly Malignant Human Cancers

TL;DR: This work identifies an HSF1-regulated transcriptional program specific to highly malignant cells and distinct from heat shock, active in breast, colon and lung tumors isolated directly from human patients and strongly associated with metastasis and death.
Journal ArticleDOI

Emerging New Concepts of Degrader Technologies.

TL;DR: In this article, the authors review key emerging technologies that exploit the lysosomal degradation pathway and discuss their potential applications and limitations, as well as emerging new degrader technologies may greatly broaden the spectrum of targets that could be selectively degraded by harnessing a second major degradation pathway in cells.
Journal ArticleDOI

Chaperoning Endoplasmic Reticulum-Associated Degradation (ERAD) and Protein Conformational Diseases.

TL;DR: The factors that constitute the ERAD machinery are discussed and detail how each step in the pathway occurs, and the underlying pathophysiology of protein conformational diseases associated with ERAD is highlighted.
Journal ArticleDOI

Proteasome storage granules protect proteasomes from autophagic degradation upon carbon starvation.

TL;DR: PSG formation and concomitant protection against proteaphagy also occurs in Arabidopsis, suggesting that PSGs represent an evolutionarily conserved cache of proteasomes that can be rapidly re-mobilized based on energy availability.
Journal ArticleDOI

Integrating the DNA damage and protein stress responses during cancer development and treatment.

TL;DR: The role of oncogene‐induced DNA damage as a driving force that shapes the cellular landscape for the emergence of the various hallmarks of cancer is emphasized and potential means to exploit key cancer‐related alterations of the genome and proteome damage response pathways are discussed in order to develop novel efficient therapeutic modalities.
References
More filters
Journal ArticleDOI

The Ubiquitin System

TL;DR: This review discusses recent information on functions and mechanisms of the ubiquitin system and focuses on what the authors know, and would like to know, about the mode of action of ubi...
Journal ArticleDOI

The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation

TL;DR: The vast majority of proteins that a cell secretes or displays on its surface first enter the endoplasmic reticulum, where they fold and assemble, and only properly assembled proteins advance from the ER to the cell surface.
Journal ArticleDOI

An nrf2/small maf heterodimer mediates the induction of phase ii detoxifying enzyme genes through antioxidant response elements

TL;DR: It is demonstrated that Nrf2 is essential for the transcriptional induction of phase II enzymes and the presence of a coordinate transcriptional regulatory mechanism for phase II enzyme genes and the nrf2-deficient mice may prove to be a very useful model for the in vivo analysis of chemical carcinogenesis and resistance to anti-cancer drugs.
Journal ArticleDOI

Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy

TL;DR: Two genes encode ubiquitin ligases that are potential drug targets for the treatment of muscle atrophy, and mice deficient in either MAFbx orMuRF1 were found to be resistant to atrophy.
Related Papers (5)